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H.V.CRlnK

SERUM THERAPY IN THE PREVElJTION AND TREATN®NT OF POLIOMYELITIS

After.the

period of the rapid growth of knowledge

of poliomyelitis, following the 1907 -1908 epidemics and
those of the succeeding ten years, the experimental
investigations, which were directly responsible for the
accessions, gradually grew less.

The reason for tae

falling off. which occurred almost simultaneously in tae
United States and in Europe, was that the studies which
for ten years had been so fruitful ceased to yield
rewarding results.

The beginning of the experimental

period dates from Landsteiners discovery in 1909 that
poliomyelitis can be communicated to monkeys by the inocu1ation of human nervous tissue and the determination
by Flexner and Lewis soon after that indefinite animal to
animal passage can be secured.

It happened that as bhe

experimeatal investigations declined, the epidemic
outbreaks also grew less.

This coincidence may have

affected somewhat the zeal with which those investigations
were persued, because with the return of epidemic waves
of the disease in America and Eutope in 1927, an inclination toward renewed study has become

apparent~

!he

return of the severer out-breaks, although localized in
/

1927 in Roumania, Germany, and in Massachusetts and
California. has oreated anew a feeling of anxiety as to
whether a more general and serious prevalance may be

impending.

~his

is olearly the feeling in oertain

looalities in the United States, in oonsequenoe of which
work has been resumed espeoially at the Rockefeller
Institute on Immunity and Specific Therapy, the results of
which follow in this paper.
No other experimental animal has shown itself
susoeptible to inoculation with the Virus, or has developed
specifio anti-bodies on repeated injeotion of viruscontaining Eervous tissues but the monkey.
The method of use in favor is the combined intrameningeal and intravenous injection of human convalescent
.'-

serum.

No decision

~s

to the best methods in humans has

been reaohed.
Rosenow's and Nuzum'S antiserum prepared by
injecting streptoooooi will no neutralize the virus of
poliomyelitis in monkeys.
,l!'lexner and Amoss showed that large intra-venous doees
of the virus are ineffeotive in monkeys when the meningeal
choroid plexns apparatus is intaot.
.,,-...

~hey

also showed that

as long as this intactness oontinues, immune serum does
not pass from the blood into the oerebro-spinal fluid.
Now in oases of poliomyelitis in man,even in the mild,
reoognisable oases, the meningeal ohoroid plexus is

~

intaot, a faot shown by the inoreasein the oellular or

protein content or both of this fluid.

When an intra-cerebral

inoculation of the virus is made in monkeys, not only is a
lesion produced in the brain at the site of the injection,
but the virus- carrying salt solution floods the meninges
and itself produces mild chemical effects which alter the
intactness.
On the basis of

th~

tests which have been made

brief~y

outlined, it is proposed that human convalescent serum
should be employed at times of stress and anxiety, when
poliomyelitis is epidemic, for producing passive immuniaation.

The doses of convalescent serum which is suggested

are 10 cc. for children and 20 cc. for adults, injected
subcutaneously and repeated after a period of four to six
weeks, if the danger still continues.
If 15 cc. of convalescent ser'm is injected into the
blood of a monkey twenty four hours before a suitable dose
of filtered virus is injected intra-cerebrally, infection
does npt take place.
The fact has been recognized that the disease is
one of low incidence and therefore the "efficacy of the
protective injections will not easily be determined.

It

is beleived that they may be used to diminish anxiety on
the part of others, but are not of course to take the
place of the usual precautions exercised to avoid exposure
to the disease.

In the passive immunization tests in monkeys, several
days

- called the incubation period of the

di~ease-

elapse

between the incubation and the appearance of the first
symptoms.

This period permits the immune anti-bodies to

become well distributed throughout the nervous system. In
pre-paralytic or early paralytic poliomyelitis in man, the
first effects of the virus have taken place, and the next
events may follow very quickly.

There is, therefore, not

the same period of days or even hours provided for the
immune bodies in the blood, to reach inconcentration all
parts of the nervous system.

This being the case it would

seem advisable, theoritically at least, that on. intra-spinal
injection of the convalescent serum should be given at the
earliest practical moment.

This will insure flooding of

the nervous tissues with anti-bodies through intermediation
of the cerebro-spinal fluid, after which the maintainance
of the anti-body contact may be left to the increased
permeability of the meningeal choroid plexus barrier to the
contents of the circulating blood.

MOae of .J:!.intry.
£resent opinion is that the virus enters and leaves
the body by way of the upper respiratory mucous membrane,
and especially in the secretions of the noso-pharynx.

The

virus has been detected in the secretions and the substance
of this membrane, both in man and monkey.

Moreover,the

monkey, a relatively resistant species, can be infected by
,

merely instilling a virus of sufficient potency into the

nares.
The precise path which the virus takes to gain access
to the brain and spinal cord from the nasal membrane can be
deduced with tolerable certainty.

The virus appears not to

pass first to the ,blood, through which it is carried to the
nervous system.

Much larger quantities of virus injected

directly into the blood do not suffice to infect monkeys.
On the other hand, there are cogent reasons for beleiving
that the virus ascends along the olfactory nerve filaments
which unite the mucous membrane of the nose
lobe of the brain.

to the olfactory

Probably the descent is also by way of

these filaments, in the reverse diEection.

Since there are

reasons for beleiving that the virus reaches not only the
brain but also the cerebro-spinal fluid in the ascent, it
is likely that the movement upward and dovmward takes place
in the lymph channels of the nerves t rather than in the axis
cylinders themselves.

Once the brain is reached in this

movement, the sprea.d of virus may spread by contiguity of
nervous tissues; but as the early clinical manif'estations
are oftener paralysis of the extremities than of the bulb,
it is inferred that the cerebro-spinal

fl~id

receives the

virus early.
However this may be,

and whether the virus ascending

alsong the olfactory nerves, works its way along the brain
to the more vulnerable spinal cord, or is carried there

by

the cerebra-spinal fluid, it is quite certain that before it
can strike injuriously it must overcome certain obstacles to
its penetration.

One of these ot,stacles, discovered by Amoss

and Taylor, resides in the nasal membrane itself; the other,
determined by Amoss and Flexnor, is bound up with the anatomical integrity of the choroid plexus and meninges.

If one

of the obstructive mechanisms fails, the other may still
operate effectively;

but if both fail, the result is

probably infection and paralysis.
appear to be partial failures

Between

th~se

two there

of the protective mechanisms,

which may be taken to account for that wide, if not yet
accurately defined, set of clinical manifestations yielding
immunity from subclinical and the several clinically abortive
forms of poliomyelitis now described.
Since poliom¥elitis is an infectious virus disease,
from which recovery in whole or in part commonly occurs, it is
not

surpri~ing

to discover

t

in view of the general knowledge

of the class of virus disease, that recovery results from
specific immunization in which a rapid production of immune
bodies takes place.

~hese

immune bodies have been deiected

in the blood as early as the sixth day of acute illness;
and after recovery from the paralytic disease they have been
found to persist in the blood in some degree of concentration
as long as twenty years.

Moreover, they are detectable in

the blood of persons with mild and abortive attacts of
poliomyelitis

and even in So-called normal persons who have

been suspected Of sub-clinical immunization.

This last

class corresponds of course to other recognized forms of

i;J,

sub-clinical infection,~'g. diptheris, leading not to actual
illness, but to active immunity.
With this knowledge of th,e clinical pathology of
epidemic poliomyelitis before us, we may inquire whether
the employment already made immune bodies is capable of
influencing and mederating the experimantal or the natural
form of the disease.

It is apparent that the first step is

to determine the effect of the immune bodies
by convalescent serum on monkeys.

Thus far it has

fouild possible to produce immune serum in any
than the monkey.

as represented
not been

ani~al

other

Since the virus of poliomyelitis is

distince from streptococci it seems futile to employ an
anti-streptococcic serum for specific therapeutic purposes.
~he

prooess as employed by Flexnor,Amoss, and Lewis to

determine the specific proteotive powers assessed

by the

convalesoent serum was, first, to mix virus and serumoutstde
the body and injeot the mixture into the brain of monkeys.
This mode of inoculationris the severest test of infeotivity
which can be employed.

When suitable combinations of serum

and virus are used, no paralySis results.

?lhen insufficiently

neutralized virus is used the usual incubation period of the
experimental disease is prolonged, but ultimately paralysis
developes.

The next procedure is a far more severe test of

the potency

of the convalescent serum.

The virus is injected

into the brain of the monkey. followed by serum injected by
lumbar puncture into the cerebrospinal fluid.

then the virus

is introduced into the brain, it is deposited into injured
brain tissue, under conditions favourable for its production
and. multiplication.

A part always passes to the cerebrospinal

fluid and is carried

everywhere in the cerebrospinal axis,

including of course the vulnerable spinal cord.

In this

experiment it was hoped that the serum placed in the cerebrospinal fluid would penetrate the nervous tissues, meet and
destroy or neutralize the virus.

This result has been

actually achieved.
By means of these experimental observations was found a

basis for specific serum therapy of poliomyelitis in man. It
has now become the reitLe to inject the serum before obvious
paralYSis occurs.

This pre-paralytic stage of pblmomyelitis

can be detecte by means of accurate labratory methods.
It has been learned that the virus of poliomyelitis
passes from the nasal mucosa to the nervous system.
well known that complex chemicals

t

It is

including protein, do

not pass from the blood to the cerebrospinal fluid as long as
the meninges and choroid plexus are anatomically
intact.
,
These structures constitute a real barrier
and the substance of the brain and cord.

between the blood

»Ut the barrier is

very sensitively adjusted, and can quite readily be impaired
by artificial means.

The injection of so innocent a fluid as

Ringer's Solution, and the even more innocent fluid-from
another monkey of the same species, into the sub-arachnoid
space, suffices to open the barrier.

When the serum is

injected by lumbar puncture, a marked aseptic meningitis
is produced and the gates are thrown wide open to the
constituents of the blood.
~he

effects of this impairment can be shown by placing

on the nasal mucosa a virus in itself

incapable of producing

poliomyelitis, or injecting into the blood
virus impotent in the normal monkey.

a quantity of

In both instances,

infection and paralysis may follow.
However, this anatomical and physiological impairment
of the meninges and choriod plexus may be rendered ineffective
if convalescent serum is introduced into the spinal fluid.
~y

this means the action of the virus in the nares and the

blood may be effectively blocked.
Now, in all cases of symptomatic poliomyelitis now matter
how mild, changes are probably to be found in the oerebrospinal fluid.

These changes are signs of inflammation, and

inflammation indicates a broken barrier.
circumstances

Under these

convalescent serum injected into the blood, •

may pass into the cerebro-spinal fluid and act to prevent and
stop an impending virus infection.
Uolvalescent serum introduced into the blood of monkeys
will prevent an intracerabrai injection of poliomyelitis
virus from producing paralysis.

It is hardly necessary to

point out the significant application of this observation.
If in time of danger of epidemic poliomyelitis

t

adequate

supplies of human convalescent serum were available, they
could~doubtless

be employed for purposes of passive immun-

ization.
The specific treatment is carried out by injecting
the serum into the subarachnoid space and into the blood.
A question arising at this time is; do the effects of the
serum so

inject~d

pass off quickly or are they endured for

a time.

It has been found that when 2 cc. of convalescent

serum are injected by lumbar puncture, monkeys are protected
against the intra-cerabral inoculation of the virus for at
/-

-

least four days.

...he opinion is therefore, that while the

first spinal injection is essential, the second may not be
so, and that the continued presence of immune serum in the
nervous tissue may be sufficiently provided for by the
convalescent serum which has been injected into the blood.
Therapy with Human Serum.
Serum from persons who have recovered fDom an attact
of poliomyelitis possesses some power to neutralize the
virus in vitro.

Serum from persons who have been in contact

with cases of frank poliomyelitis possesses this power in
equal or greater degree
actually been ill.

than serum from those who have

Serum from normal adults never in contact

wi th known 'cases of the disease seems to possess neutralizing
power at least equal to that of persons known to have been

in contact with the aisease.
appears to b' more potent

Moreover, normal adult serum

in its action against the virus

in these in vitro tests than is the serum of convalescents.
Serum from normal infants

between six months and two years

of age Beems almost devoid of neutralizing powers.
These results may be thus interpreted:

The normal

infant of a few months of age has no immunity against
poliomyelitis, but immunity to poliomyelitis gradually
developes with age so that most adults are immune.
persons are attackeq by the disease

~efore

Some

sufficient

immunity has developed to afford protection. The immunity
1__

following the attact does not appear to be so great, judging
by the neutralization test, as the immunity acquired by,the
"normal" person; this is true also of diptheria.

While such

an hypothesis seems adequate to explain the known facts, it
remains to be prooved that there is a direct relation between
immunity to poliomyelitis

and the possesion of serum with

virus neutralizing properties. Aycock's work, as well as that
of Rhoades and Stewart has prooved that serum from artificially
immunized monkeys

possesses neutralizing properties.

ent work of Aycock and Kramer

The

rec~

with serums from the Virgin

Islands indicates that the virus is distributed as widely in
areas where the disease is not knows to be endemic as in tee

,-

United States.

This suggests that the factor, which determines \':

whether the first reaction to the virus is to be immunity or
int'ection is bound up in peculiarities of the indiv1dual

attacked.

Perhaps the sarne

v~riations

within the individual

as those which govern the seasonal incidenoe of the disease.
These results may prove of praotioal importance in that they
suggest that the serum of normal adults, properly tested
beforehand for neutralizing potenoy, may be used therapeutioally with as much promise of releif as when convalescent
serum is used.

Extensive labratory and clinioal investiga-

tionsmust. of oourse, be made before it is certain that a
serum that neutralizes in vitro will also be effective
against the virus in vivo.
been established

.--

Such a correlation seems to have

for convalescent serum.

That this same

correlation may exist for normal serum from man is indiaated
by the results

of Lingher, who 'got about the same results

from either serum.

Serum Treatment in

~oliomyelitis.

Experimentally, tne neutralizing or protecting power of
human immune serum has been conclusively proved.

ln 1910

Levadi ti and Landsteiner, ]'1exner and Lewis, and others
demonstrated that lee. of human or monkey convalescent serum
rubbed up with 0.3co. of cord suspension, a fatal dose of
virus, would neutralize that virus in vitro, in that this
combined intra-dural implantation in monkeys was not followed
by the otherwise usual development of the disease.

Also

twenty four hours after the intra-dural injection of a fatal
dose of virus, 10ce. of convalescent serum given intra-spinally
likewise protected the monkey from paralysis.
..~

Injections of

serum given later than twenty four nours were not so successful in aborting tne process.

These results were at onee

utilized. as a basis :t:'or serum tnerapy in man.
The methOd is as
Blood

~s

~ollows:

collected

~rom

individuals wno have recovered

from the disease preferable within a four year period.
However, dOll.ors with paralysis of 20 years standing were aleo
,~

used, with no apparent difference in results.

The serum is

carefully separated and inactivated; to it may be added as a
preservative 0.2

%tri-cresol.

obtained by paying for it.

In Syracuse, this serum was

About 2500cs. of blood is usually

taken from adults and about 100Ces. of clear serum is obtained.

Administration of the serum is most usually intraspinally but may be given by other routes.
/~

In brief, the

dosage and mode of administration for the intra-spinal
method is as follows:
with

~is

The patient is placed on his side

knees drawn up.

The back' is prepared with Iodine

and a; lumbar puncture is done.

The spinal fluid is exam-

ined at the bedside with a small portable microscope thus
confirming the diagnosis.

As much fluid as Can be obtained

is withdrawn. Withdrawal of

~luid

may be continuen untill

definite nuchal pain is oomplained of.

If more than 2000s.

of spinal fluid is obtained, GOocs. of warm serum is introduced

by means of a syringe through the lumbar punoture

needle.

Care Should be used not to put the serum in under

pressure.

~he

amounts of serum given vary from 10 to 2500s.

acoording to the size and age Of the individual.

It is now

beleived that one mistake of the earlier eases was too small
dosage; 10 ee. in an infant is not too large, and 25 co.
Should

be given to an adult.

Sucoessful results have also

been obtained by giving the serum intravenously or intramuscularly". The dosage of' the serum given by these methods
is the same as by the intra-spinal method.
Reaotions to the serum treatment are frequent but are
seldom alarming.

The most common reaotion is an increase

in the meningeal signs, inorEl'ased stif:fness in the neok and
baok and the presenoe of a Kernig sign.

This is accompan-

ied with an increased oell count of the spinal fluid, whion

may become turbid..

The cellular response does not necessar-

ily parallel the clinical signee

The amount of fluid may

be increased, or decreased at the second puncture.
The next most common reaction is a chill with a sharp
rise in temperature, which may reach 105 F. and is frequently
accompanied by vomiting.

This comes on in twenty or thirty

minutes and is like that during certain transfusions. Whether
or not blood typing would reduce the frequency of this
reaction is not known.
Another reaction is abdominal pain and pain referred to
the legs after the spinal injection.

-

severe.

This is occasionly very

However, it is usually of Short duration.

Delayed reactions such as urticaria and arthritis are
rare if ever present with the human serum injeotion.
Untoward reactions are rare and those seen conSisted o:f
marked increase o:f meningeal signs and coma lasting for 24
or 48 hours.
The decision for a repeated administration of serum is
often a'delioate one and much depend.s upon the accuracy of
observation.

In general it is considered gOOd therapy to

give a second injection if the temperature observations at
the eighteenth to the twentieth hour shows a fever of 101 F.

-,

or more.

The spinal

t~uid

is usually clOUdy

serum and is no true index of aotivity.

±~om

the first

However,some

observers advise the serum administration only as the cell

counts are two hundred or over.

The determination by temper-

ature is considered the safest determination.

This decision

should mainly rest with the consultant, who should again see
the patient at this period.

There is rarely the opportunity

@f a third dose as the patient is either paral1zed or

ed after a second.
his case.

recover~

Again, the attending physician must watcn

Temporization with "waiting till tomorrow" is often

disastrous.
In 1916 thirty six early cases were treated with intra.spinal serum; nineteen cases sleared without paralysis. Sometimes, due to lack of immediately available human convalescent
serum, normal human, pneumococcic, and normal horse serum
were given, and given mainly on an empirical basis, but
surprizingly, often with equally favourable results.

These

non-specific results and the then reported nigh incidence of
the abortive case made analysis difIicult and observors at
this time were somewhat guarded in their opinion, feeling
that such recoveries might be cOinCidental, but since that
r--..

time and. mainly by experiEmce here presented, they are now
convinced as to the value of serum treatment and earnestly
advise it as the proper procedure in the early period of this
d.isease.
Of a series of twenty three cases given anti-pneumocoocic
serum alone and eight which were given an initial dose of

of pneumoccic serum and a subsequent dose ot' hu.man convalescent serum.

As far as can be determined from such a small

number, there is no great difference in results as compared
to the human immune serum.

This fact is very disturbing,

since it is non-specific therapy.

Little explanation has

been offered, except that the apparently beneficial results
may be partially due to the phagocytic action of the additional
aseptic meningitis produced by this introduction of a foreign
serum.
However,

it is strongly urged that the human

cent serum on the experimental evidence 'be used.

conv~les

It should

also be remembered that the introduction of pneumococcas
serum or other

non-sp~cific

horse serum is often attended

later by severe reactions with urticaria, joint inflammation
and acute kidney irritation.

Many severe reactions have

been noted in cases previously sensitized to diptheria toxin
anti-toxin.
immune serum.

Such serum Sickness does not occur with human
For the greater part it has only been used

when human immune serum was not available.
showed in the experimental animal, that

Flexner and Amoss

the intra-spinal

introduction of horse serum seemed to increase the susceptibility to the virus.
Serum in the Paralytic Stage.
The intra-spinal administration of serum to the paralized

cases is considered:f:'utile, but sometimes decision in the
early paralytic stage is a difficult one.

It is often

demanded by the parents and attending physician. Paralysis
well established, cannot be very much a.ffected by serum,
but in the very early hours

0:1:"

paralysis with the temper-

sture remaining high, it has been the plan to examine the
spinal fluid and if" the cell count is above 200, serum is
given, this on the premise that if, in the early meningeal
stage it is of value, then it might also be still of value
in neutralizing the virus still present and possibly active
in the surrounding meninges.
In bulbar types puncture and intra-spinal serum are
contraindicated.

These patients are to be left severely

alone and must be kept absolutely quiet.

With Such quiet

,

they sometimes "slip-by" and the added disturbance by
puncture and serum might well reverse the bala.nce.
Intravenous serum is recommended by
others but is difficult of attainment.

Amos~

Draper and

It necessitates a
"

large amount of serum which is not always available and, in
the opinion of some, such treatment is not necessary.

Uonclusions.
1.

That Human convalescent serum offers the best means

of treatment for epidemic poliomyelitis.
2.

That convalescent serum must be given in the pre-

paralytic stage in order to be of benefit.
3.

''chat human convalescent serum is the best treatment

for the prevention of poliomyelitis when the disease is
endemic.
4.

The initial dosage in infants should be 10cc ••n~ for

adults 20cc.
5.

That no better method of administration has been

found than the intraspinal route.
G.

That in the future outbreaks of the disease may be

successfully treated with human convalescent serum.

Referenoes.
Edwin D. Ebright - The Treatment of Acute Polio-Mylitis.
J.Kans.Med.Soc. Vol.50 pp.76-8l,March,1929.
W.Lloyd Aycock,Eliot R. Luther, S.D.Kramervalescent Serum Therapy J.A.M.A.

Technic of Con-

92;385 Feb.2,1929.

J.M.McEachern, Bruce Chown. Lennox G.Bell,Mary McKenzie.
Reaume of the Results of Therapy with Convaleaoent Serum in
Poliomyelitis. Can.Med.Assoc. J.Vol. 20:369: Apl.1929.
Shaw and Thelander, J.A.M.A. 90:1925;1928.
Romer and Joseph, Munch Med. 57: 567,1910.
Wardner D.Ayer,

Poliomyelitis-preparalyticperiod and Serum Therapy

AM.J. MED.SCI. 177,540, ApriI,1929.
Rex L. Dively, Anterior Poliomyelitis.
J. of

~one

and Joint Surgery, vol.11 1929.

Simon Flexner - Fred W. stewart. Specific Prevention and Treatment
of Epidemic Poliomyelitis.
Transations of the Assoc. of Am. :E)ysicians Vo143!p252!1929
~imon

Flexner - Specific Preventlon and Treatment of Poliomyelitis.
International Clinics - Vol 1, P 57,39 series, 1929.

Howard J. Shaugh nessy, Paul H. Harmon, Francis B.Gordon
The Neutralization of Poliomyelitis Virus by Human Serum.
The J. of Prevo Med. Nov.1930, vol. 4 No.6, P 463 •

•

